Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,340 | 55,844 | 91,938 | 90,677 | 142,086 |
| Marketable Securities | 125,201 | 134,190 | 131,913 | 122,436 | 89,734 |
| Receivables | 3,267 | 400 | N/A | N/A | N/A |
| Inventories | 1,513 | N/A | N/A | N/A | N/A |
| TOTAL | $166,592 | $196,805 | $228,366 | $217,755 | $236,350 |
| Non-Current Assets | |||||
| PPE Net | 981 | 1,060 | 1,127 | 1,206 | 1,293 |
| Investments And Advances | 4,983 | 14,997 | 14,990 | 0 | 0 |
| Intangibles | 18,740 | 19,000 | 0 | 0 | 0 |
| Other Non-Current Assets | 103,355 | 3,305 | 3,185 | 3,280 | 3,221 |
| TOTAL | $128,059 | $38,362 | $19,302 | $4,486 | $4,514 |
| Total Assets | $294,651 | $235,167 | $247,668 | $222,241 | $240,864 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,166 | 5,003 | 5,380 | 5,658 | 3,151 |
| Accrued Expenses | 30,723 | 43,847 | 20,775 | 27,781 | 13,411 |
| Other current liabilities | 1,996 | 847 | 2,202 | 930 | 1,264 |
| TOTAL | $42,596 | $50,387 | $29,028 | $35,022 | $18,462 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 131,843 | 128,384 | 122,903 | 53,336 | 50,307 |
| TOTAL | $131,843 | $128,384 | $122,903 | $53,336 | $50,307 |
| Total Liabilities | $174,439 | $178,771 | $151,931 | $88,358 | $68,769 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,730 | 30,638 | 30,516 | 30,453 | 30,420 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -257,159 | -314,705 | -267,597 | -223,703 | -173,171 |
| Other shareholders' equity | -35 | -6 | -13 | 0 | 83 |
| TOTAL | $120,212 | $56,396 | $95,737 | $133,883 | $172,095 |
| Total Liabilities And Equity | $294,651 | $235,167 | $247,668 | $222,241 | $240,864 |